| Literature DB >> 32513211 |
Zongjie Li1, Canhui Liu1, Yuanguo Liu1, Sheng Yao1, Biao Xu1, Guohua Dong2.
Abstract
BACKGROUND: As an extensive surgery, minimally invasive esophagectomy (MIE) has advantages in reducing morbidity and improving quality of life for patients suffering from esophageal cancer. This study aims to investigate differences between MIE and open esophagectomy (OE) for considerations of the safety of procedures, rate of tumor resection, postoperative complications, and quality of life. This paper also tends to provide some references for MIE on esophageal cancer therapy.Entities:
Keywords: Cervical anastomosis; Esophageal carcinoma; Minimally invasive esophagectomy; Open esophagectomy; Retrospective analysis
Year: 2020 PMID: 32513211 PMCID: PMC7282040 DOI: 10.1186/s13019-020-01182-3
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Preoperative Characteristics of Patient and Tumor
| Characteristics | OE ( | MIE ( | |
|---|---|---|---|
| Gender (%) | 0.532 | ||
| Male | 73.58% | 79.31% | |
| Female | 26.42% | 20.69% | |
| Age (years) | 63.02 ± 6.84 | 64.75 ± 7.80 | 0.241 |
| BMI (kg/m2) | 21.51 ± 1.56 | 21.75 ± 1.53 | 0.421 |
| ASA grade (%) | 0.122 | ||
| I | 35.85% | 27.59% | |
| II | 50.94% | 48.28% | |
| III | 13.21% | 24.13% | |
| Smoking history (%) | 67.92% | 74.71% | 0.442 |
| Tumor stage (%) | 0.662 | ||
| T1 | 12% | 21% | |
| T2 | 68% | 54% | |
| T3 | 20% | 25% | |
| Comorbidity (%) | 0.462 | ||
| Hypertension | 50.94% | 74.71% | |
| Diabetes | 9.4% | 13.79% | |
| Coronary artery disease | 15.09% | 24.14% | |
| Cardiac arrhythmia | 5.66% | 10.34% | |
| Pulmonary disease | 33.96% | 35.63% | |
| History of stroke | 9.43% | 11.49% | |
| Neoadjuvant therapy (%) | 5.66% | 8.05% | 0.742 |
Scale variables were expressed as median and range, ordinal and nominal parameters as absolute numbers, and percent
ASA American Society of Anesthesiologists, BMI Body mass index.
1Mann-Whitney test
2Chi-square (or Fisher exact) test.
Perioperative and oncologic outcomes
| Variable | OE ( | MIE ( | |
|---|---|---|---|
| Operation time (min) | 200.34 ± 14.51 | 146.08 ± 17.35 | < 0.00011 |
| Intraoperative blood loss (mL) | 174.53 ± 35.32 | 83.91 ± 24.72 | < 0.00011 |
| Blood transfusion (%) | 3.77%-2/53 | 2.30%-2/87 | 0.632 |
| Postoperative ICU stay (hours) | 21.75 ± 1.68 | 21.15 ± 1.54 | 0.071 |
| Postoperative hospital stay (days) | 15.64 ± 6.05 | 9.68 ± 2.97 | < 0.00011 |
| R0-resection rate (%) | 100%-53/53 | 100%-87/87 | 1.002 |
| Lymph nodes retrieved | 18.42 ± 3.66 | 38.89 ± 4.31 | < 0.00011 |
| Postoperative pathological staging | 0.282 | ||
| I | 22.64% | 21.83% | |
| II | 58.49% | 47.13% | |
| III | 18.87% | 31.03% |
Scale variables were expressed as median and range, ordinal and nominal parameters as absolute numbers, and percent
ICU Intensive care unit
1Mann-Whitney test
2Chi-square (or Fisher exact) test
Postoperative complications and mortality
| Variable | OE ( | MIE ( | |
|---|---|---|---|
| Anastomotic leakage (%) | 5.66% | 8.05% | 0.742 |
| Pulmonary infection (%) | 20.75% | 31.03% | 0.242 |
| Atrial fibrillation (%) | 16.98% | 21.84% | 0.522 |
| Vocal cord paralysis (%) | 0% | 3.45% | 0.282 |
| Regurgitation (%) | 26.42% | 29.89% | 0.702 |
| Chylothorax (%) | 3.77% | 1.15% | 0.562 |
| Intestinal obstruction (%) | 3.77% | 1.15% | 0.562 |
| Diaphragmatic hernia (%) | 0% | 0% | 1.002 |
| Wound infection (%) | 3.77% | 0% | 0.142 |
| In-hospital mortality (%) | 1.75% | 1.15% | 1.002 |
Scale variables were expressed as median and range, ordinal and nominal parameters as absolute numbers, and percent. 2Chi-square (or Fisher exact) test.
Short-term (3 months) postoperative outcomes on morbidity, mortality and quality of life
| Variable | OE ( | MIE ( | |
|---|---|---|---|
| Stenosis anastomosis | 1.92% | 2.33% | 1.002 |
| Regurgitation | 15.38% | 23.26% | 0.652 |
| Pneumonia | 3.77% | 8.14% | 0.482 |
| Recurrence | 0% | 0% | 1.002 |
| Mortality | 0% | 3.49% | 0.292 |
| EORTC C30 Global health | 66.10 ± 5.43 | 66.42 ± 5.92 | 0.051 |
Scale variables were expressed as median and range, ordinal and nominal parameters as absolute numbers, and percent. 1Mann-Whitney test; 2Chi-square (or Fisher exact) test EORTC: European Organization for Research and Treatment of Cancer Quality of Life Questionnaires. EORTC C30 Global health: scores range from 0 to 100, with higher scores representing better well-being.